Aytu Biopharma (AYTU) Gross Profit Growth (1y) (2015 - 2026)

Aytu Biopharma (AYTU) Gross Profit Growth (1y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 5.06%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 2.59%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -7.66%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -37.68%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 42.12%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 14.77%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -163.22%
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -2.85%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -7.87%
10 Aytu Biopharma 23.76 Mn -2.96 Mn 7.60 Mn -40.66%

Historic Data

Download Data
DateValue
Mar 31, 2026 -40.66%
Dec 31, 2025 -10.77%
Sep 30, 2025 -23.35%
Jun 30, 2025 -7.22%
Mar 31, 2025 23.60%
Dec 31, 2024 -26.14%
Sep 30, 2024 -8.08%
Jun 30, 2024 -40.47%
Mar 31, 2024 -18.69%
Dec 31, 2023 -15.56%
Sep 30, 2023 -27.70%
Jun 30, 2023 25.08%
Mar 31, 2023 0.45%
Dec 31, 2022 40.60%
Sep 30, 2022 44.77%
Jun 30, 2022 31.36%
Dec 31, 2021 38.25%
Sep 30, 2021 31.71%
Jun 30, 2021 18.19%
Dec 31, 2020 246.29%